Enlivex (ENLV) Reports $1.87M Q2 Loss, Cuts Cash Burn Nearly 40%
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) is a clinical-stage biopharmaceutical company based in Israel that is pioneering a novel approach…
Browsing Tag